Mangumpit, Max Kaiden .

HRN: 21-94-28  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2025
CEFTRIAXONE 1G (VIAL)
08/01/2025
08/07/2025
IVT
1.3g
Q24
Typhoid Fever
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: